Benzinga | Dec 6, 2021 06:17AM EST

Wells Fargo Upgrades Edwards Lifesciences to Overweight, Announces $126 Price Target

Wells Fargo analyst Larry Biegelsen upgrades Edwards Lifesciences (NYSE:EW) from Equal-Weight to Overweight and announces $126 price target.